Jakarta - Delayed Quote IDR

PT Medikaloka Hermina Tbk (HEAL.JK)

1,080.00 -5.00 (-0.46%)
As of 3:31 PM GMT+7. Market Open.
Loading Chart for HEAL.JK
DELL
  • Previous Close 1,085.00
  • Open 1,085.00
  • Bid --
  • Ask --
  • Day's Range 1,065.00 - 1,125.00
  • 52 Week Range 1,060.00 - 1,575.00
  • Volume 7,837,900
  • Avg. Volume 9,161,128
  • Market Cap (intraday) 15.969T
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 36.33
  • EPS (TTM) 29.73
  • Earnings Date Apr 26, 2024 - Apr 29, 2024
  • Forward Dividend & Yield 7.00 (0.65%)
  • Ex-Dividend Date Jun 12, 2023
  • 1y Target Est 1,766.70

PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. It is also involved in the investment, service, and trading business activities. The company was founded in 1985 and is based in Jakarta, Indonesia.

www.herminahospitals.com

16,258

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: HEAL.JK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HEAL.JK
27.52%
IDX COMPOSITE
2.97%

1-Year Return

HEAL.JK
20.75%
IDX COMPOSITE
3.44%

3-Year Return

HEAL.JK
20.50%
IDX COMPOSITE
17.28%

5-Year Return

HEAL.JK
61.42%
IDX COMPOSITE
10.73%

Compare To: HEAL.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HEAL.JK

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    16.04T

  • Enterprise Value

    17.45T

  • Trailing P/E

    36.50

  • Forward P/E

    24.10

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.76

  • Price/Book (mrq)

    4.15

  • Enterprise Value/Revenue

    3.02

  • Enterprise Value/EBITDA

    15.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.56%

  • Return on Assets (ttm)

    6.23%

  • Return on Equity (ttm)

    11.32%

  • Revenue (ttm)

    5.78T

  • Net Income Avi to Common (ttm)

    437.35B

  • Diluted EPS (ttm)

    29.73

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    855.64B

  • Total Debt/Equity (mrq)

    43.49%

  • Levered Free Cash Flow (ttm)

    -441.26B

Research Analysis: HEAL.JK

Analyst Price Targets

1,410.00
1,766.70 Average
1,080.00 Current
1,980.00 High
 

Fair Value

 

Company Insights: HEAL.JK

People Also Watch